Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men...
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued o
Target Price
The average target price of BTMD is 3.1 and suggests 125% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell